AVITA Medical, Inc.
RCEL
$4.11
$0.205.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.34M | -48.59M | -48.56M | -51.57M | -57.05M |
| Total Depreciation and Amortization | 2.40M | 2.29M | 2.06M | 1.79M | 1.44M |
| Total Amortization of Deferred Charges | 53.00K | 53.00K | -- | -- | -- |
| Total Other Non-Cash Items | 10.96M | 11.61M | 14.00M | 13.88M | 15.41M |
| Change in Net Operating Assets | 967.00K | 3.44M | -1.34M | 70.00K | 1.81M |
| Cash from Operations | -30.96M | -31.20M | -33.84M | -35.83M | -38.38M |
| Capital Expenditure | -803.00K | -1.01M | -3.29M | -6.12M | -8.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.53M | 13.46M | 18.20M | 33.76M | 41.31M |
| Cash from Investing | 3.73M | 12.45M | 14.91M | 27.65M | 33.06M |
| Total Debt Issued | 49.08M | -- | -- | -- | -- |
| Total Debt Repaid | -42.98M | -- | -- | -- | -- |
| Issuance of Common Stock | 15.63M | 15.99M | 16.77M | 2.95M | 3.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.06M | -1.06M | -1.06M | -- | -- |
| Cash from Financing | 20.67M | 14.94M | 15.71M | 2.95M | 3.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.56M | -3.81M | -3.22M | -5.24M | -2.08M |